Abstract
Isoenzymes in the human prostate gland are reviewed in depth by Dr. C.B. Brendler in the preceding chapter. The author focused his attention on the marker enzymes of clinical importance, i.e., acid and alkaline phosphatases, lactate dehydrogenase, creatine kinase and leucine aminopeptidase. Valuable information on the comparative aspect of prostatic and erythrocytic prostatic acid phosphatases was presented in Table I, in which the biochemical characteristics of the various forms of acid phosphatases were cited. It would, however, have perhaps been more beneficial to the readers if the author had provided similar tables for each of the other isoenzymes discussed. Nonetheless, this chapter successfully conveys the current status of isoenzymes in the human prostate gland, the general biochemical methodologies that have been used to characterize them, and the application of quantitative procedures for these isoenzymes pertinent to prostatic cancer. The author points out the potential and future challenge for urological researchers to discover markers that would have clinical value in diagnosing and staging of prostatic cancer in man, particularly in the early phases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Li HC, Chemoff J, Chen LB, Kirschenbauw A: A phosphotyrosylprotein phosphatase activity associated with acid phosphatase from human prostate gland. European Journal of Biochem 138, 45–51, 1984
Hunter T, Sefton BM: Transforming gene product of rous sarcoma virus phosphorylates tyrosine. Proc Natl Acad Sci USA 77, 1311–1315, 1980
Collett MS, Purchio AF, Erikson RL: Avian sarcoma virus-transforming protein, p 60,shows protein kinase activity specific for tyrosine. Nature 285: 167–169, 1980
Levinson AD, Oppermann H, Varmus HE, Bishop JM: The purified product of the transforming gene of avian sarcoma virus phosphorylates tyrosine. J of Biol Chem 255: 11973–11979, 1980
Wang MC, Pepsidero LD, Kuriyama M, Valenzuela LA, Murphy GP: Prostate antigen: a new potential marker for prostatic cancer. The Prostate 2: 89–96, 1981
Silverman LM, Chapman JF, Jones ME, Dermer GB, Pullano T, Tokes ZA: Creatine kinase BB and other markers of prostatic carcinoma. The Prostate 2: 109–119, 1981
Fishman WH: Immunology and biochemistry of the Regan isoenzyme. The Prostate 1: 399–410, 1980
Parker MG, Mainwaring WIP: Effects of androgens on the complexity of poly (A) RNA from rat prostate. Cell. 12: 401–407, 1977
Montpetit ML, Lawless KR, Tenniswood M: Androgen repressed messages in the rat ventral prostate. The Prostate 8: 25–36, 1986
Smith RG, Nag A: Regulation of c-sis expression in tumors of the male reproductive tract: In Assessment of Current Concepts and Approaches to the Study of Prostatic Cancer, Coffey DS, Chiarodo A, Karr J (eds). Prouts Neck Maine October 18–20, 1985
Fleming WH, Hamel A, MacDonald R, Ramsey E, Pettigraw NM, Johnston B, Dodd JG, Matusik RJ: Expression of the c-myc protooncogene in human prostatic carcinoma and benign prostatic hyperplasia. Cancer Research 46: 1535–1538, 1986
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1987 Martinus Nijhoff Publishers, Boston
About this chapter
Cite this chapter
Chung, L.W.K. (1987). Editorial Comment. In: Ratliff, T.L., Catalona, W.J. (eds) Genitourinary Cancer. Cancer Treatment and Research, vol 34. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-2033-3_2
Download citation
DOI: https://doi.org/10.1007/978-1-4613-2033-3_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-9210-4
Online ISBN: 978-1-4613-2033-3
eBook Packages: Springer Book Archive